Back to Search
Start Over
Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
- Source :
-
Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2016 Dec 01; Vol. 148, pp. 629-639. Date of Electronic Publication: 2016 Sep 28. - Publication Year :
- 2016
-
Abstract
- In an earlier study we demonstrated that hydroxyapatite nanoparticles coated with chitosan-poly(d,l)-lactide-co-glycolide (HAp/Ch-PLGA) target lungs following their intravenous injection into mice. In this study we utilize an emulsification process and freeze drying to load the composite HAp/Ch-PLGA particles with 17β-hydroxy-17α-picolyl-androst-5-en-3β-yl-acetate (A), a chemotherapeutic derivative of androstane and a novel compound with a selective anticancer activity against lung cancer cells. <superscript>1</superscript> H NMR and <superscript>13</superscript> C NMR techniques confirmed the intact structure of the derivative A following its entrapment within HAp/Ch-PLGA particles. The thermogravimetric and differential thermal analyses coupled with mass spectrometry were used to assess the thermal degradation products and properties of A-loaded HAp/Ch-PLGA. The loading efficiency, as indicated by the comparison of enthalpies of phase transitions in pure A and A-loaded HAp/Ch-PLGA, equaled 7.47wt.%. The release of A from HAp/Ch-PLGA was sustained, neither exhibiting a burst release nor plateauing after three weeks. Atomic force microscopy and particle size distribution analyses were used to confirm that the particles were spherical with a uniform size distribution of d <subscript>50</subscript> =168nm. In vitro cytotoxicity testing of A-loaded HAp/Ch-PLGA using MTT and trypan blue dye exclusion assays demonstrated that the particles were cytotoxic to the A549 human lung carcinoma cell line (46±2%), while simultaneously preserving high viability (83±3%) of regular MRC5 human lung fibroblasts and causing no harm to primary mouse lung fibroblasts. In conclusion, composite A-loaded HAp/Ch-PLGA particles could be seen as promising drug delivery platforms for selective cancer therapies, targeting malignant cells for destruction, while having a significantly lesser cytotoxic effect on the healthy cells.<br /> (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Subjects :
- A549 Cells
Androstanes pharmacokinetics
Androstanes pharmacology
Animals
Antineoplastic Agents pharmacokinetics
Antineoplastic Agents pharmacology
Cell Line
Cell Survival drug effects
Cells, Cultured
Drug Liberation
Fibroblasts cytology
Fibroblasts drug effects
Fibroblasts metabolism
Humans
Lung Neoplasms metabolism
Lung Neoplasms pathology
Magnetic Resonance Spectroscopy
Mass Spectrometry
Mice, Inbred C57BL
Microscopy, Atomic Force
Microscopy, Confocal
Nanoparticles chemistry
Particle Size
Polylactic Acid-Polyglycolic Acid Copolymer
Spectroscopy, Fourier Transform Infrared
Thermogravimetry
Androstanes chemistry
Antineoplastic Agents chemistry
Chitosan chemistry
Durapatite chemistry
Lactic Acid chemistry
Polyglycolic Acid chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1873-4367
- Volume :
- 148
- Database :
- MEDLINE
- Journal :
- Colloids and surfaces. B, Biointerfaces
- Publication Type :
- Academic Journal
- Accession number :
- 27694053
- Full Text :
- https://doi.org/10.1016/j.colsurfb.2016.09.041